Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs

Cancer incidence and mortality continue to increase, while the conventional chemotherapeutic drugs confer limited efficacy and relevant toxic side effects. Novel strategies are urgently needed for more effective and safe therapeutics in oncology. However, a large number of proteins are considered un...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartolucci, Damiano, Pession, Andrea, Hrelia, Patrizia, Tonelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315662/
https://www.ncbi.nlm.nih.gov/pubmed/35890348
http://dx.doi.org/10.3390/pharmaceutics14071453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315662/
https://www.ncbi.nlm.nih.gov/pubmed/35890348
http://dx.doi.org/10.3390/pharmaceutics14071453

Ejemplares similares